vs
ANAPTYSBIO, INC(ANAB)与REGIS CORP(RGS)财务数据对比。点击上方公司名可切换其他公司
ANAPTYSBIO, INC的季度营收约是REGIS CORP的1.9倍($108.2M vs $57.1M),ANAPTYSBIO, INC净利率更高(45.8% vs 0.8%,领先45.0%),ANAPTYSBIO, INC同比增速更快(151.1% vs 22.3%),ANAPTYSBIO, INC自由现金流更多($98.0M vs $891.0K),过去两年ANAPTYSBIO, INC的营收复合增速更高(288.3% vs 7.8%)
AnaptysBio是一家处于临床阶段的生物技术企业,专注于开发适用于炎症疾病、肿瘤免疫及罕见病领域的抗体类免疫疗法,主要面向美国市场,推进创新候选药物管线研发以满足未被满足的临床需求。
瑞吉斯公司是一家美国美发沙龙运营商,总部位于明尼苏达州明尼阿波利斯市。截至2021年8月,该集团旗下拥有5563家加盟沙龙以及276家直营门店,是北美地区规模领先的美发沙龙连锁经营企业。
ANAB vs RGS — 直观对比
营收规模更大
ANAB
是对方的1.9倍
$57.1M
营收增速更快
ANAB
高出128.8%
22.3%
净利率更高
ANAB
高出45.0%
0.8%
自由现金流更多
ANAB
多$97.1M
$891.0K
两年增速更快
ANAB
近两年复合增速
7.8%
损益表 — Q4 FY2025 vs Q2 FY2026
| 指标 | ||
|---|---|---|
| 营收 | $108.2M | $57.1M |
| 净利润 | $49.6M | $456.0K |
| 毛利率 | — | — |
| 营业利润率 | 61.8% | 10.8% |
| 净利率 | 45.8% | 0.8% |
| 营收同比 | 151.1% | 22.3% |
| 净利润同比 | 327.8% | -94.0% |
| 每股收益(稀释后) | $1.64 | $0.16 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配
营收
ANAB
RGS
| Q4 25 | $108.2M | $57.1M | ||
| Q3 25 | $76.3M | $59.0M | ||
| Q2 25 | $22.3M | $60.4M | ||
| Q1 25 | $27.8M | $57.0M | ||
| Q4 24 | $43.1M | $46.7M | ||
| Q3 24 | $30.0M | $46.1M | ||
| Q2 24 | $11.0M | $49.4M | ||
| Q1 24 | $7.2M | $49.2M |
净利润
ANAB
RGS
| Q4 25 | $49.6M | $456.0K | ||
| Q3 25 | $15.1M | $1.4M | ||
| Q2 25 | $-38.6M | $116.5M | ||
| Q1 25 | $-39.3M | $250.0K | ||
| Q4 24 | $-21.8M | $7.6M | ||
| Q3 24 | $-32.9M | $-853.0K | ||
| Q2 24 | $-46.7M | $91.2M | ||
| Q1 24 | $-43.9M | $-2.3M |
营业利润率
ANAB
RGS
| Q4 25 | 61.8% | 10.8% | ||
| Q3 25 | 45.5% | 10.0% | ||
| Q2 25 | -117.5% | 12.1% | ||
| Q1 25 | -99.2% | 8.8% | ||
| Q4 24 | -22.4% | 11.8% | ||
| Q3 24 | -75.8% | 4.6% | ||
| Q2 24 | -367.5% | — | ||
| Q1 24 | -587.8% | 8.3% |
净利率
ANAB
RGS
| Q4 25 | 45.8% | 0.8% | ||
| Q3 25 | 19.8% | 2.3% | ||
| Q2 25 | -173.5% | 192.9% | ||
| Q1 25 | -141.6% | 0.4% | ||
| Q4 24 | -50.5% | 16.4% | ||
| Q3 24 | -109.4% | -1.9% | ||
| Q2 24 | -425.3% | 184.7% | ||
| Q1 24 | -612.0% | -4.7% |
每股收益(稀释后)
ANAB
RGS
| Q4 25 | $1.64 | $0.16 | ||
| Q3 25 | $0.52 | $0.49 | ||
| Q2 25 | $-1.34 | $43.67 | ||
| Q1 25 | $-1.28 | $0.08 | ||
| Q4 24 | $-0.63 | $2.71 | ||
| Q3 24 | $-1.14 | $-0.36 | ||
| Q2 24 | $-1.71 | $38.40 | ||
| Q1 24 | $-1.64 | $-1.00 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | ||
|---|---|---|
| 现金及短期投资手头流动性 | $238.2M | $18.4M |
| 总债务越低越好 | — | $113.3M |
| 股东权益账面价值 | $37.2M | $188.7M |
| 总资产 | $364.4M | $588.3M |
| 负债/权益比越低杠杆越低 | — | 0.60× |
8季度趋势,按日历期对齐
现金及短期投资
ANAB
RGS
| Q4 25 | $238.2M | $18.4M | ||
| Q3 25 | $109.8M | $16.6M | ||
| Q2 25 | $44.3M | $17.0M | ||
| Q1 25 | $98.6M | $13.3M | ||
| Q4 24 | $123.1M | $10.2M | ||
| Q3 24 | $191.6M | $6.3M | ||
| Q2 24 | $71.8M | $10.1M | ||
| Q1 24 | $53.7M | $5.9M |
总债务
ANAB
RGS
| Q4 25 | — | $113.3M | ||
| Q3 25 | — | $111.3M | ||
| Q2 25 | — | $110.8M | ||
| Q1 25 | — | $112.0M | ||
| Q4 24 | — | $111.5M | ||
| Q3 24 | — | $95.2M | ||
| Q2 24 | — | $99.5M | ||
| Q1 24 | — | $179.7M |
股东权益
ANAB
RGS
| Q4 25 | $37.2M | $188.7M | ||
| Q3 25 | $-29.4M | $187.6M | ||
| Q2 25 | $-44.7M | $185.6M | ||
| Q1 25 | $34.0M | $68.6M | ||
| Q4 24 | $70.9M | $66.7M | ||
| Q3 24 | $84.4M | $56.4M | ||
| Q2 24 | $9.9M | $56.8M | ||
| Q1 24 | $47.8M | $-35.8M |
总资产
ANAB
RGS
| Q4 25 | $364.4M | $588.3M | ||
| Q3 25 | $353.1M | $592.1M | ||
| Q2 25 | $335.3M | $599.0M | ||
| Q1 25 | $422.1M | $511.2M | ||
| Q4 24 | $483.8M | $530.1M | ||
| Q3 24 | $493.4M | $508.9M | ||
| Q2 24 | $427.4M | $530.5M | ||
| Q1 24 | $405.8M | $543.7M |
负债/权益比
ANAB
RGS
| Q4 25 | — | 0.60× | ||
| Q3 25 | — | 0.59× | ||
| Q2 25 | — | 0.60× | ||
| Q1 25 | — | 1.63× | ||
| Q4 24 | — | 1.67× | ||
| Q3 24 | — | 1.69× | ||
| Q2 24 | — | 1.75× | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | ||
|---|---|---|
| 经营现金流最新季度 | $98.0M | $1.7M |
| 自由现金流经营现金流 - 资本支出 | $98.0M | $891.0K |
| 自由现金流率自由现金流/营收 | 90.5% | 1.6% |
| 资本支出强度资本支出/营收 | 0.0% | 1.4% |
| 现金转化率经营现金流/净利润 | 1.98× | 3.65× |
| 过去12个月自由现金流最近4个季度 | $19.6M | $14.9M |
8季度趋势,按日历期对齐
经营现金流
ANAB
RGS
| Q4 25 | $98.0M | $1.7M | ||
| Q3 25 | $-27.4M | $2.3M | ||
| Q2 25 | $-40.2M | $6.8M | ||
| Q1 25 | $-10.7M | $6.2M | ||
| Q4 24 | $-66.7M | $2.1M | ||
| Q3 24 | $-10.1M | $-1.3M | ||
| Q2 24 | $-21.3M | $5.1M | ||
| Q1 24 | $-37.3M | $-277.0K |
自由现金流
ANAB
RGS
| Q4 25 | $98.0M | $891.0K | ||
| Q3 25 | $-27.4M | $1.9M | ||
| Q2 25 | $-40.3M | $6.2M | ||
| Q1 25 | $-10.7M | $5.9M | ||
| Q4 24 | $-66.9M | $1.7M | ||
| Q3 24 | $-10.1M | $-1.4M | ||
| Q2 24 | $-21.4M | $5.1M | ||
| Q1 24 | $-37.3M | $-326.0K |
自由现金流率
ANAB
RGS
| Q4 25 | 90.5% | 1.6% | ||
| Q3 25 | -35.9% | 3.2% | ||
| Q2 25 | -180.9% | 10.3% | ||
| Q1 25 | -38.7% | 10.3% | ||
| Q4 24 | -155.3% | 3.6% | ||
| Q3 24 | -33.7% | -3.0% | ||
| Q2 24 | -194.6% | 10.3% | ||
| Q1 24 | -519.3% | -0.7% |
资本支出强度
ANAB
RGS
| Q4 25 | 0.0% | 1.4% | ||
| Q3 25 | 0.0% | 0.7% | ||
| Q2 25 | 0.2% | 0.9% | ||
| Q1 25 | 0.1% | 0.6% | ||
| Q4 24 | 0.6% | 0.9% | ||
| Q3 24 | 0.1% | 0.0% | ||
| Q2 24 | 0.3% | 0.0% | ||
| Q1 24 | 0.4% | 0.1% |
现金转化率
ANAB
RGS
| Q4 25 | 1.98× | 3.65× | ||
| Q3 25 | -1.81× | 1.68× | ||
| Q2 25 | — | 0.06× | ||
| Q1 25 | — | 24.80× | ||
| Q4 24 | — | 0.28× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | 0.06× | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ANAB
暂无分部数据
RGS
| Franchise Segment | $37.9M | 66% |
| Royalty | $13.6M | 24% |
| Other | $2.8M | 5% |
| Fees | $1.8M | 3% |
| Franchise Fees | $1.0M | 2% |